Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area (Oncology), Modality (Small Molecules, Vaccine), End User (Pharma & CROs) & Region

The global Central lab services/clinical trial lab services market is projected to reach USD 8.18 billion by 2030 from USD 5.97 billion in 2025, at a CAGR of 6.5% during the forecast period.

This is due to increasing adoption of drug discovery, as the adoption increases the demand for these services rises. Additionally, increasing government support to provide grants for healthcare is increasing, thus rising the number of clinical trials, consequently increasing the demand for the central lab clinical service trial. However, the high cost associated with the clinical trial methods are the major restraint to the market. Additionally, the shortage of trained healthcare professionals & limited knowledge about the services is major challenge for the market growth. But is creating a conducive environment for market expansion over the forecast period of 2025-2030.

The pharmaceutical & biopharmaceutical companies segment of central lab services/clinical trial lab services market by end user to hold largest position forecast period.

Based on the end user, the central lab services/clinical trial lab services market is divided into pharmaceutical & biopharmaceutical companies, CROS, medical device companies, and other end users. Among these, in 2024 pharmaceutical & biopharmaceutical companie segment account for the largest market share of 61.8% in central lab services/clinical trial lab services market. This is due to the rising prevalence of rare disease. Majority of the pharmaceutical companies are conducting the clinical trials for the cure of such diseases via advanced technologies. Thus, majority of the companies prefer these services. Thus, as the prevalence of these diseases is increasing the need for long term treatment is rising, consequently increasing the demand for central lab services/clinical trial lab services market.

The oncology segment accounts for the largest market share in central lab services/clinical trial lab services market.

Based on theraprutic area, the central lab services/clinical trial lab services market is segmented into oncology, infectious diseases, neurology, cardiology, and other therapeutic areas. The oncology segment holds for the largest market share in central lab services/clinical trial lab services market due to increasing number of cancer patients. Oncology clinical trials often require modern diagnostic testing, including biomarker testing, genomic testing, and tumor profiling, to assess the effectiveness and safety of new cancer therapies in clinical trials. Central labs are important in providing these services, ensuring that testing is viable, consistent, and compliant with regulatory standards across multiple sites. With the rising focus on precision medicine, the need for specialized and high-quality lab testing in oncology is significant, making the oncology segment the largest and most critical in the central lab services market.

Asia Pacific is the fastest growing region of the central lab services/clinical trial lab services market by region.

The global central lab services/clinical trial lab services market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the fastest growing regional market for entral lab services/clinical trial lab services and is estimated to grow at the highest CAGR during the forecast period. This is due to increasing prevalence of rare diseases and rising population across the region.

Asia Pacific region includes Japan, China, India, and Rest of Asia Pacific. Among these, China accounts for the largest market share in central lab services/clinical trial lab services market in 2024. This is due to its rapid expansion of pharmaceutical and biotechnology industries, added with the with a large patient population and increasing demand for innovative treatments. The country's growing healthcare infrastructure, investment in clinical research, and supportive regulatory environment have made it an attractive hub for global clinical trials.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1 - 48%, Tier 2 - 36%, and Tier 3 - 16%
By Designation: C-level - 25%, Director-level - 30% and Others - 45%
By Region: North America - 40%, Europe - 25%, Asia Pacific - 20%, Latin America - 10%, and Middle east and Africa - 5%
Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = more than USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = less than USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.- Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the central lab services/clinical trial lab services market are Thermo Fisher Scientific Inc. (US), IQVIA (US), ICON plc (Ireland), Labcorp (US), Quest Diagnostics (US), Charles River Laboratories (US), Medpace (US), Frontage lab (US), SGS Société Générale de Surveillance SA (Switzerland), Eurofins Scientific (Luxembourg), and REPROCELL Inc. (Japan).

Research Coverage

This report studies the central lab services/clinical trial lab services market based on product, type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Analysis of Key divers (Increasing number of clinical trials, increasing investments in research & development, growing prevalence of rare diseases), restraints (High cost associated with clinicaltrials, Shortage of skilled professionals), opportunity (Emerging markets worldwide, decentralized and virtual clinical trials), Challenge (regulatory complexities, limited patient diversity and cybersecurity or intellectual property concerns)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the central lab services/clinical trial lab services market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the central lab services/clinical trial lab services market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the pain management devices market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

1 Introduction

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered and Regional Scope
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders

2 Research Methodology

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Key Data from Primary Sources
2.1.2.4 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.1.1 Approach 1: Company Revenue Estimation Approach
2.2.1.2 Approach 2: Presentations of Companies and Primary Interviews
2.2.1.3 Approach 3: Primary Interviews
2.2.1.4 Growth Forecast
2.2.1.5 CAGR Projections
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.4.1 Study-Related Assumptions
2.4.2 Parametric Assumptions
2.5 Research Limitations
2.6 Risk Assessment

3 Executive Summary

4 Premium Insights

4.1 Central Lab Services/Clinical Trial Lab Services Market Overview
4.2 Asia-Pacific Central Lab Services/Clinical Trial Lab Services Market, by End-user and Country
4.3 Central Lab Services/Clinical Trial Lab Services Market, by Country
4.4 Central Lab Services/Clinical Trial Lab Services Market, Regional Mix, 2025 vs. 2030

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Clinical Trials
5.2.1.2 Rising Investments in Research & Development
5.2.1.3 Growing Prevalence of Rare Diseases
5.2.1.4 Favorable Government Initiatives
5.2.2 Restraints
5.2.2.1 High Costs Associated with Clinical Trials
5.2.2.2 Shortage of Skilled Professionals
5.2.3 Opportunities
5.2.3.1 Emerging Markets Worldwide
5.2.3.2 Decentralized and Virtual Clinical Trials
5.2.4 Challenges
5.2.4.1 Regulatory Complexities
5.2.4.2 Limited Patient Diversity
5.2.4.3 Cybersecurity and Intellectual Property Concerns
5.3 Trends/Disruptions Impacting Customer Business
5.4 Value Chain Analysis
5.4.1 Resource Acquisition and Preparation
5.4.2 Clinical Trial Execution
5.4.3 Data Reporting and Result Submission
5.4.4 Promotion and Regulatory Filing
5.5 Ecosystem Analysis
5.6 Investment and Funding Scenario
5.7 Technology Analysis
5.7.1 Key Technologies
5.7.1.1 Enzyme-Linked Immunosorbent Assay
5.7.2 Adjacent Technologies
5.7.2.1 Next-Generation Sequencing
5.8 Key Conferences and Events, 2025-2026
5.9 Case Study Analysis
5.9.1 Phase 3 Clinical Trial to Compare Efficacy and Safety of Two Combination Therapies (Cerba Research)
5.10 Regulatory Landscape
5.10.1 Regulatory Framework
5.10.1.1 North America
5.10.1.2 Europe
5.10.1.3 Asia-Pacific
5.10.1.4 Rest of the World
5.10.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.11 Porter's Five Forces Analysis
5.11.1 Threat of New Entrants
5.11.2 Threat of Substitutes
5.11.3 Bargaining Power of Suppliers
5.11.4 Bargaining Power of Buyers
5.11.5 Intensity of Competitive Rivalry
5.12 Key Stakeholders and Buying Criteria
5.12.1 Key Stakeholders in Buying Process
5.12.2 Buying Criteria
5.13 Impact of AI/Generative AI on Central Lab Services/Clinical Trial Lab Services Market
5.13.1 Introduction
5.13.2 Market Potential of Central Lab Services/Clinical Trial Lab Services
5.13.3 AI Use Cases
5.13.4 Future of Generative AI in Clinical Trial Lab Ecosystem

6 Central Lab Services/Clinical Trial Lab Services Market, by Phase

6.1 Introduction
6.2 Phase I
6.2.1 Need to Assess Safety, Dosage, and Potential Side Effects of Drugs to Aid Growth
6.3 Phase II
6.3.1 Need to Evaluate Desired Effect and Additional Safety Data of Drugs to Drive Market
6.4 Phase III
6.4.1 Rising Inclination Toward Confirming Safety and Efficacy of Drugs to Boost Market
6.5 Phase IV
6.5.1 Ongoing Safety Surveillance on Drug Trials to Augment Growth

7 Central Lab Services/Clinical Trial Lab Services Market, by Service Type

7.1 Introduction
7.2 Safety Testing
7.2.1 Need to Ensure Compliance with Safety Standards to Promote Growth
7.3 Immunology
7.3.1 Increasing Focus on Immunotherapies to Stimulate Growth
7.4 Genetic Testing
7.4.1 Growing Advancements in Next-Generation Sequencing to Drive Market
7.5 Coagulation Testing
7.5.1 Essential Role in Monitoring Coagulation Disorders and Evaluating Anticoagulant Therapies to Expedite Growth
7.6 Pathology Testing
7.6.1 Ability to Provide Insights into Disease Mechanisms, Treatment Effects, and Diagnostics to Aid Growth
7.7 Biomarkers
7.7.1 Need to Examine Test Effects on Patients to Augment Growth
7.8 Companion Diagnostics
7.8.1 Growing Inclination Toward Personalized Treatments to Drive Market
7.9 Other Tests

8 Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area

8.1 Introduction
8.2 Oncology
8.2.1 Increasing Cancer Research Studies to Accelerate Growth
8.3 Infectious Diseases
8.3.1 Increasing Cases of Infectious Diseases to Encourage Growth
8.4 Neurology
8.4.1 Rising Prevalence of Neurological Disorders to Facilitate Growth
8.5 Cardiology
8.5.1 Growing Incidence of Cardiovascular Diseases to Propel Market
8.6 Other Therapeutic Areas

9 Central Lab Services/Clinical Trial Lab Services Market, by Modality

9.1 Introduction
9.2 Small Molecules
9.2.1 Emergence of Therapeutic Modalities to Amplify Growth
9.3 Biologics
9.3.1 Monoclonal Antibodies
9.3.1.1 Growing Advancements in Antibody Engineering to Drive Market
9.3.2 Vaccines
9.3.2.1 Increasing Investments in Vaccine Development to Favor Growth
9.3.3 Other Therapeutic Products
9.4 Cell & Gene Therapy
9.4.1 Outsourcing Trend to Favor Growth
9.5 Medical Devices & Ivd Devices
9.5.1 Rising Focus on Real-Time Patient Health Tracking to Boost Market

10 Central Lab Services/Clinical Trial Lab Services Market, by End-user

10.1 Introduction
10.2 Pharmaceutical & Biopharmaceutical Companies
10.2.1 Emerging Biopharma Companies to Expedite Growth
10.3 Clinical Research Organizations
10.3.1 Critical Role in Site Selection, Recruitment Support, Clinical Monitoring, and Data Collection to Drive Market
10.4 Medical Device Companies
10.4.1 Rising Focus on Quality and Safety Standards to Stimulate Growth
10.5 Other End-users

11 Central Lab Services/Clinical Trial Lab Services Market, by Region

11.1 Introduction
11.2 North America
11.2.1 Macroeconomic Outlook for North America
11.2.2 US
11.2.2.1 Increasing Clinical Trials to Support Growth
11.2.3 Canada
11.2.3.1 Rising Incidence of Chronic Diseases to Advance Growth
11.3 Europe
11.3.1 Macroeconomic Outlook for Europe
11.3.2 Germany
11.3.2.1 Increasing Healthcare Expenditure to Intensify Growth
11.3.3 France
11.3.3.1 Growing Investments in Life Sciences Sector to Boost Market
11.3.4 UK
11.3.4.1 High Number of Oncology Clinical Trials to Facilitate Growth
11.3.5 Italy
11.3.5.1 Rising Focus on Streamlining Clinical Trial Process to Expedite Growth
11.3.6 Spain
11.3.6.1 Emerging Biotech Companies to Bolster Growth
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Macroeconomic Outlook for Asia-Pacific
11.4.2 Japan
11.4.2.1 Growing Demand for Drug Development to Propel Market
11.4.3 China
11.4.3.1 Booming Pharmaceutical Industry to Drive Market
11.4.4 India
11.4.4.1 Increasing Regulatory Reforms to Foster Growth
11.4.5 Rest of Asia-Pacific
11.5 Latin America
11.5.1 Robust Manufacturing Infrastructure to Sustain Growth
11.5.2 Macroeconomic Outlook for Latin America
11.6 Middle East & Africa
11.6.1 Growing Demand for Outsourcing Services to Fuel Market
11.6.2 Macroeconomic Outlook for Middle East & Africa

12 Competitive Landscape

12.1 Overview
12.2 Key Player Strategies/Right to Win
12.2.1 Overview of Strategies Adopted by Key Players in Central Lab Services/Clinical Trial Lab Services Market
12.3 Revenue Analysis, 2020-2024
12.4 Market Share Analysis, 2024
12.5 Company Valuation and Financial Metrics
12.6 Brand/Product Comparison
12.7 Company Evaluation Matrix: Key Players, 2024
12.7.1 Stars
12.7.2 Emerging Leaders
12.7.3 Pervasive Players
12.7.4 Participants
12.7.5 Company Footprint: Key Players, 2024
12.7.5.1 Company Footprint
12.7.5.2 Region Footprint
12.7.5.3 Product Type Footprint
12.7.5.4 Therapeutic Area Footprint
12.7.5.5 Phase Footprint
12.8 Company Evaluation Matrix: Startups/SMEs, 2024
12.8.1 Progressive Companies
12.8.2 Responsive Companies
12.8.3 Dynamic Companies
12.8.4 Starting Blocks
12.8.5 Competitive Benchmarking: Startups/SMEs, 2024
12.8.5.1 Detailed List of Key Startups/SMEs
12.8.5.2 Competitive Benchmarking of Key Startups/SMEs
12.9 Competitive Scenario
12.9.1 Product Launches
12.9.2 Deals
12.9.3 Expansions
12.9.4 Other Developments

13 Company Profiles

13.1 Key Players
13.1.1 Thermo Fisher Scientific Inc.
13.1.1.1 Business Overview
13.1.1.2 Products/Services Offered
13.1.1.3 Recent Developments
13.1.1.3.1 Product Launches
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.4 Analyst's View
13.1.1.4.1 Key Strengths
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses and Competitive Threats
13.1.2 Iqvia
13.1.2.1 Business Overview
13.1.2.2 Products/Services Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Product Launches
13.1.2.3.2 Deals
13.1.2.4 Analyst's View
13.1.2.4.1 Right to Win
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses and Competitive Threats
13.1.3 Icon PLC
13.1.3.1 Business Overview
13.1.3.2 Products/Services Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Product Launches
13.1.3.3.2 Deals
13.1.3.4 Analyst's View
13.1.3.4.1 Right to Win
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses and Competitive Threats
13.1.4 Charles River Laboratories
13.1.4.1 Business Overview
13.1.4.2 Products/Services Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Deals
13.1.4.3.2 Expansions
13.1.4.4 Analyst's View
13.1.4.4.1 Right to Win
13.1.4.4.2 Strategic Choices
13.1.4.4.3 Weaknesses and Competitive Threats
13.1.5 Labcorp
13.1.5.1 Business Overview
13.1.5.2 Products/Services Offered
13.1.5.3 Recent Developments
13.1.5.3.1 Product Launches
13.1.5.3.2 Deals
13.1.5.3.3 Expansions
13.1.5.3.4 Other Developments
13.1.5.4 Analyst's View
13.1.5.4.1 Key Strengths
13.1.5.4.2 Strategic Choices
13.1.5.4.3 Weaknesses and Competitive Threats
13.1.6 Quest Diagnostics
13.1.6.1 Business Overview
13.1.6.2 Products/Services Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Deals
13.1.7 Medpace
13.1.7.1 Business Overview
13.1.7.2 Products/Services Offered
13.1.7.3 Recent Developments
13.1.7.3.1 Expansions
13.1.8 Frontage Labs
13.1.8.1 Business Overview
13.1.8.2 Products/Services Offered
13.1.9 Sgs Société Générale De Surveillance SA
13.1.9.1 Business Overview
13.1.9.2 Products/Services Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Deals
13.1.10 Eurofins Scientific
13.1.10.1 Business Overview
13.1.10.2 Products/Services Offered
13.1.10.3 Recent Developments
13.1.10.3.1 Deals
13.1.11 Reprocell Inc.
13.1.11.1 Business Overview
13.1.11.2 Products/Services Offered
13.1.11.3 Recent Developments
13.1.11.3.1 Deals
13.1.12 Acm Global Laboratories
13.1.12.1 Business Overview
13.1.12.2 Products/Services Offered
13.1.12.3 Recent Developments
13.1.12.3.1 Deals
13.2 Other Players
13.2.1 Worldwide Clinical Trials
13.2.2 Versiti
13.2.3 Cti Clinical Trial & Consulting
13.2.4 Clarity Laboratories, Inc
13.2.5 Novotech
13.2.6 Arup Laboratories
13.2.7 Precision Medicine Group
13.2.8 Bioagilytix Labs
13.2.9 Cerba Healthcare
13.2.10 Almac Group
13.2.11 Mlm Medical Labs
13.2.12 Salvus Bioresearch Solutions Llp
13.2.13 Unilabs

14 Appendix

14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options

List of Tables

Table 1 Central Lab Services/Clinical Trial Lab Services Market: Inclusions and Exclusions
Table 2 Central Lab Services/Clinical Trial Lab Services Market: Risk Assessment
Table 3 Traditional vs. Virtual Clinical Trials
Table 4 Central Lab Services/Clinical Trial Lab Services Market: Role of Companies in Ecosystem
Table 5 Central Lab Services/Clinical Trial Lab Services Market: Key Conferences and Events, 2025-2026
Table 6 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 7 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 8 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 9 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 Regulatory Scenario for Drug Approvals and Cgmp Procedures
Table 12 Central Lab Services/Clinical Trial Lab Services Market: Porter's Five Forces Analysis
Table 13 Influence of Stakeholders on Buying Process, by End-user (%)
Table 14 Key Buying Criteria, by End-user
Table 15 Key Companies Implementing AI
Table 16 Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 18 Companies Providing Phase I Services
Table 19 Central Lab Services/Clinical Trial Lab Services Market for Phase I, by Region, 2022-2030 (USD Million)
Table 20 North America: Central Lab Services/Clinical Trial Lab Services Market for Phase I Services, by Country, 2022-2030 (USD Million)
Table 22 Europe: Central Lab Services/Clinical Trial Lab Services Market for Phase I Services, by Country, 2022-2030 (USD Million)
Table 23 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Phase I Services, by Country, 2022-2030 (USD Million)
Table 24 Companies Providing Phase II Services
Table 25 Central Lab Services/Clinical Trial Lab Services Market for Phase II Services, by Region, 2022-2030 (USD Million)
Table 26 North America: Central Lab Services/Clinical Trial Lab Services Market for Phase II Services, by Country, 2022-2030 (USD Million)
Table 27 Europe: Central Lab Services/Clinical Trial Lab Services Market for Phase II Services, by Country, 2022-2030 (USD Million)
Table 28 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Phase II Services, by Country, 2022-2030 (USD Million)
Table 29 Companies Providing Phase III Services
Table 30 Central Lab Services/Clinical Trial Lab Services Market for Phase III Services, by Region, 2022-2030 (USD Million)
Table 31 North America: Central Lab Services/Clinical Trial Lab Services Market for Phase III Services, by Country, 2022-2030 (USD Million)
Table 32 Europe: Central Lab Services/Clinical Trial Lab Services Market for Phase III Services, by Country, 2022-2030 (USD Million)
Table 33 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Phase III Services, by Country, 2022-2030 (USD Million)
Table 34 Companies Providing Phase IV Services
Table 35 Central Lab Services/Clinical Trial Lab Services Market for Phase IV Services, by Region, 2022-2030 (USD Million)
Table 36 North America: Central Lab Services/Clinical Trial Lab Services Market for Phase IV Services, by Country, 2022-2030 (USD Million)
Table 37 Europe: Central Lab Services/Clinical Trial Lab Services Market for Phase IV Services, by Country, 2022-2030 (USD Million)
Table 38 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Phase IV Services, by Country, 2022-2030 (USD Million)
Table 39 Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 40 Central Lab Services/Clinical Trial Lab Services Market for Safety Testing, by Region, 2022-2030 (USD Million)
Table 41 North America: Central Lab Services/Clinical Trial Lab Services Market for Safety Testing, by Country, 2022-2030 (USD Million)
Table 42 Europe: Central Lab Services/Clinical Trial Lab Services Market for Safety Testing, by Country, 2022-2030 (USD Million)
Table 43 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Safety Testing, by Country, 2022-2030 (USD Million)
Table 44 Central Lab Services/Clinical Trial Lab Services Market for Immunology, by Region, 2022-2030 (USD Million)
Table 45 North America: Central Lab Services/Clinical Trial Lab Services Market for Immunology, by Country, 2022-2030 (USD Million)
Table 46 Europe: Central Lab Services/Clinical Trial Lab Services Market for Immunology, by Country, 2022-2030 (USD Million)
Table 47 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Immunology, by Country, 2022-2030 (USD Million)
Table 48 Central Lab Services/Clinical Trial Lab Services Market for Genetic Testing, by Region, 2022-2030 (USD Million)
Table 49 North America: Central Lab Services/Clinical Trial Lab Services Market for Genetic Testing, by Country, 2022-2030 (USD Million)
Table 50 Europe: Central Lab Services/Clinical Trial Lab Services Market for Genetic Testing, by Country, 2022-2030 (USD Million)
Table 51 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Genetic Testing, by Country, 2022-2030 (USD Million)
Table 52 Central Lab Services/Clinical Trial Lab Services Market for Coagulation Testing, by Region, 2022-2030 (USD Million)
Table 53 North America: Central Lab Services/Clinical Trial Lab Services Market for Coagulation Testing, by Country, 2022-2030 (USD Million)
Table 54 Europe: Central Lab Services/Clinical Trial Lab Services Market for Coagulation Testing, by Country, 2022-2030 (USD Million)
Table 55 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Coagulation Testing, by Country, 2022-2030 (USD Million)
Table 56 Central Lab Services/Clinical Trial Lab Services Market for Pathology Testing, by Region, 2022-2030 (USD Million)
Table 57 North America: Central Lab Services/Clinical Trial Lab Services Market for Pathology Testing, by Country, 2022-2030 (USD Million)
Table 58 Europe: Central Lab Services/Clinical Trial Lab Services Market for Pathology Testing, by Country, 2022-2030 (USD Million)
Table 59 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Pathology Testing, by Country, 2022-2030 (USD Million)
Table 60 Central Lab Services/Clinical Trial Lab Services Market for Biomarkers, by Region, 2022-2030 (USD Million)
Table 61 North America: Central Lab Services/Clinical Trial Lab Services Market for Biomarkers, by Country, 2022-2030 (USD Million)
Table 62 Europe: Central Lab Services/Clinical Trial Lab Services Market for Biomarkers, by Country, 2022-2030 (USD Million)
Table 63 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Biomarkers, by Country, 2022-2030 (USD Million)
Table 64 Central Lab Services/Clinical Trial Lab Services Market for Companion Diagnostics, by Region, 2022-2030 (USD Million)
Table 65 North America: Central Lab Services/Clinical Trial Lab Services Market for Companion Diagnostics, by Country, 2022-2030 (USD Million)
Table 66 Europe: Central Lab Services/Clinical Trial Lab Services Market for Companion Diagnostics, by Country, 2022-2030 (USD Million)
Table 67 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Companion Diagnostics, by Country, 2022-2030 (USD Million)
Table 68 Central Lab Services/Clinical Trial Lab Services Market for Other Tests, by Region, 2022-2030 (USD Million)
Table 69 North America: Central Lab Services/Clinical Trial Lab Services Market for Other Tests, by Country, 2022-2030 (USD Million)
Table 70 Europe: Central Lab Services/Clinical Trial Lab Services Market for Other Tests, by Country, 2022-2030 (USD Million)
Table 71 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Other Tests, by Country, 2022-2030 (USD Million)
Table 72 Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 73 Central Lab Services/Clinical Trial Lab Services Market for Oncology, by Region, 2022-2030 (USD Million)
Table 74 North America: Central Lab Services/Clinical Trial Lab Services Market for Oncology, by Country, 2022-2030 (USD Million)
Table 75 Europe: Central Lab Services/Clinical Trial Lab Services Market for Oncology, by Country, 2022-2030 (USD Million)
Table 76 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Oncology, by Country, 2022-2030 (USD Million)
Table 77 Central Lab Services/Clinical Trial Lab Services Market for Infectious Diseases, by Region, 2022-2030 (USD Million)
Table 78 North America: Central Lab Services/Clinical Trial Lab Services Market for Infectious Diseases, by Country, 2022-2030 (USD Million)
Table 79 Europe: Central Lab Services/Clinical Trial Lab Services Market for Infectious Diseases, by Country, 2022-2030 (USD Million)
Table 80 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Infectious Diseases, by Country, 2022-2030 (USD Million)
Table 81 Central Lab Services/Clinical Trial Lab Services Market for Neurology, by Region, 2022-2030 (USD Million)
Table 82 North America: Central Lab Services/Clinical Trial Lab Services Market for Neurology, by Country, 2022-2030 (USD Million)
Table 83 Europe: Central Lab Services/Clinical Trial Lab Services Market for Neurology, by Country, 2022-2030 (USD Million)
Table 84 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Neurology, by Country, 2022-2030 (USD Million)
Table 85 Central Lab Services/Clinical Trial Lab Services Market for Cardiology, by Region, 2022-2030 (USD Million)
Table 86 North America: Central Lab Services/Clinical Trial Lab Services Market for Cardiology, by Country, 2022-2030 (USD Million)
Table 87 Europe: Central Lab Services/Clinical Trial Lab Services Market for Cardiology, by Country, 2022-2030 (USD Million)
Table 88 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Cardiology, by Country, 2022-2030 (USD Million)
Table 89 Central Lab Services/Clinical Trial Lab Services Market for Other Therapeutic Areas, by Region, 2022-2030 (USD Million)
Table 90 North America: Central Lab Services/Clinical Trial Lab Services Market for Other Therapeutic Areas, by Country, 2022-2030 (USD Million)
Table 91 Europe: Central Lab Services/Clinical Trial Lab Services Market for Other Therapeutic Areas, by Country, 2022-2030 (USD Million)
Table 92 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Other Therapeutic Areas, by Country, 2022-2030 (USD Million)
Table 93 Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 94 Central Lab Services/Clinical Trial Lab Services Market for Small Molecules, by Region, 2022-2030 (USD Million)
Table 95 North America: Central Lab Services/Clinical Trial Lab Services Market for Small Molecules, by Country, 2022-2030 (USD Million)
Table 96 Europe: Central Lab Services/Clinical Trial Lab Services Market for Small Molecules, by Country, 2022-2030 (USD Million)
Table 97 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Small Molecules, by Country, 2022-2030 (USD Million)
Table 98 Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 99 Central Lab Services/Clinical Trial Lab Services Market for Biologics, by Region, 2022-2030 (USD Million)
Table 100 North America: Central Lab Services/Clinical Trial Lab Services Market for Biologics, by Country, 2022-2030 (USD Million)
Table 101 Europe: Central Lab Services/Clinical Trial Lab Services Market for Biologics, by Country, 2022-2030 (USD Million)
Table 102 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Biologics, by Country, 2022-2030 (USD Million)
Table 103 Central Lab Services/Clinical Trial Lab Services Market for Monoclonal Antibodies, by Region, 2022-2030 (USD Million)
Table 104 North America: Central Lab Services/Clinical Trial Lab Services Market for Monoclonal Antibodies, by Country, 2022-2030 (USD Million)
Table 105 Europe: Central Lab Services/Clinical Trial Lab Services Market for Monoclonal Antibodies, by Country, 2022-2030 (USD Million)
Table 106 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Monoclonal Antibodies, by Country, 2022-2030 (USD Million)
Table 107 Central Lab Services/Clinical Trial Lab Services Market for Vaccines, by Region, 2022-2030 (USD Million)
Table 108 North America: Central Lab Services/Clinical Trial Lab Services Market for Vaccines, by Country, 2022-2030 (USD Million)
Table 109 Europe: Central Lab Services/Clinical Trial Lab Services Market for Vaccines, by Country, 2022-2030 (USD Million)
Table 110 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Vaccines, by Country, 2022-2030 (USD Million)
Table 111 Central Lab Services/Clinical Trial Lab Services Market for Other Therapeutic Products, by Region, 2022-2030 (USD Million)
Table 112 North America: Central Lab Services/Clinical Trial Lab Services Market for Other Therapeutic Products, by Country, 2022-2030 (USD Million)
Table 113 Europe: Central Lab Services/Clinical Trial Lab Services Market for Other Therapeutic Products, by Country, 2022-2030 (USD Million)
Table 114 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Other Therapeutic Products, by Country, 2022-2030 (USD Million)
Table 115 Central Lab Services/Clinical Trial Lab Services Market for Cell & Gene Therapy, by Region, 2022-2030 (USD Million)
Table 116 North America: Central Lab Services/Clinical Trial Lab Services Market for Cell & Gene Therapy, by Country, 2022-2030 (USD Million)
Table 117 Europe: Central Lab Services/Clinical Trial Lab Services Market for Cell & Gene Therapy, by Country, 2022-2030 (USD Million)
Table 118 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Cell & Gene Therapy, by Country, 2022-2030 (USD Million)
Table 119 Central Lab Services/Clinical Trial Lab Services Market for Medical Devices & Ivd Devices, by Region, 2022-2030 (USD Million)
Table 120 North America: Central Lab Services/Clinical Trial Lab Services Market for Medical Devices & Ivd Devices, by Country, 2022-2030 (USD Million)
Table 121 Europe: Central Lab Services/Clinical Trial Lab Services Market for Medical Devices & Ivd Devices, by Country, 2022-2030 (USD Million)
Table 122 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Medical Devices & Ivd Devices, by Country, 2022-2030 (USD Million)
Table 123 Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 124 Central Lab Services/Clinical Trial Lab Services Market for Pharmaceutical & Biopharmaceutical Companies, by Region, 2022-2030 (USD Million)
Table 125 North America: Central Lab Services/Clinical Trial Lab Services Market for Pharmaceutical & Biopharmaceutical Companies, by Country, 2022-2030 (USD Million)
Table 126 Europe: Central Lab Services/Clinical Trial Lab Services Market for Pharmaceutical & Biopharmaceutical Companies, by Country, 2022-2030 (USD Million)
Table 127 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Pharmaceutical & Biopharmaceutical Companies, by Country, 2022-2030 (USD Million)
Table 128 Central Lab Services/Clinical Trial Lab Services Market for Cros, by Region, 2022-2030 (USD Million)
Table 129 North America: Central Lab Services/Clinical Trial Lab Services Market for Cros, by Country, 2022-2030 (USD Million)
Table 130 Europe: Central Lab Services/Clinical Trial Lab Services Market for Cros, by Country, 2022-2030 (USD Million)
Table 131 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Cros, by Country, 2022-2030 (USD Million)
Table 132 Central Lab Services/Clinical Trial Lab Services Market for Medical Device Companies, by Region, 2022-2030 (USD Million)
Table 133 North America: Central Lab Services/Clinical Trial Lab Services Market for Medical Device Companies, by Country, 2022-2030 (USD Million)
Table 134 Europe: Central Lab Services/Clinical Trial Lab Services Market for Medical Device Companies, by Country, 2022-2030 (USD Million)
Table 135 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Medical Device Companies, by Country, 2022-2030 (USD Million)
Table 136 Central Lab Services/Clinical Trial Lab Services Market for Other End-users, by Region, 2022-2030 (USD Million)
Table 137 North America: Central Lab Services/Clinical Trial Lab Services Market for Other End-users, by Country, 2022-2030 (USD Million)
Table 138 Europe: Central Lab Services/Clinical Trial Lab Services Market for Other End-users, by Country, 2022-2030 (USD Million)
Table 139 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market for Other End-users, by Country, 2022-2030 (USD Million)
Table 140 Central Lab Services/Clinical Trial Lab Services Market, by Region, 2022-2030 (USD Million)
Table 141 Macroeconomic Indicators for North America
Table 142 North America: Central Lab Services/Clinical Trial Lab Services Market, by Country, 2022-2030 (USD Million)
Table 143 North America: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 144 North America: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 145 North America: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 146 North America: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 147 North America: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 148 North America: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 149 US: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 150 US: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 151 US: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 152 US: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 153 US: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 154 US: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 155 Canada: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 156 Canada: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 157 Canada: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 158 Canada: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 159 Canada: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 160 Canada: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 161 Macroeconomic Indicators for Europe
Table 162 Europe: Central Lab Services/Clinical Trial Lab Services Market, by Country, 2022-2030 (USD Million)
Table 163 Europe: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 164 Europe: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 165 Europe: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 166 Europe: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 167 Europe: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 168 Europe: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 169 Germany: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 170 Germany: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 171 Germany: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 172 Germany: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 173 Germany: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 174 Germany: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 175 France: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 176 France: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 177 France: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 178 France: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 179 France: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 180 France: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 181 UK: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 182 UK: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 183 UK: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 184 UK: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 185 UK: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 186 UK: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 187 Italy: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 188 Italy: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 189 Italy: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 190 Italy: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 191 Italy: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 192 Italy: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 193 Spain: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 194 Spain: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 195 Spain: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 196 Spain: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 197 Spain: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 198 Spain: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 199 Rest of Europe: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 200 Rest of Europe: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 201 Rest of Europe: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 202 Rest of Europe: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 203 Rest of Europe: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 204 Rest of Europe: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 205 Macroeconomic Indicators for Asia-Pacific
Table 206 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Country, 2022-2030 (USD Million)
Table 207 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 208 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 209 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 210 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 211 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 212 Asia-Pacific Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 213 Japan: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 214 Japan: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 215 Japan: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 216 Japan: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 217 Japan: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 218 Japan: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 219 China: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 220 China: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 221 China: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 222 China: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 223 China: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 224 China: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 225 India: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 226 India: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 227 India: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 228 India: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 229 India: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 230 India: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 231 Rest of Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 232 Rest of Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 233 Rest of Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 234 Rest of Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 235 Rest of Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 236 Rest of Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 237 Macroeconomic Indicators for Latin America
Table 238 Latin America: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 239 Latin America: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 240 Latin America: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 241 Latin America: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 242 Latin America: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 243 Latin America: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 244 Macroeconomic Indicators for Middle East & Africa
Table 245 Middle East & Africa: Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2022-2030 (USD Million)
Table 246 Middle East & Africa: Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2022-2030 (USD Million)
Table 247 Middle East & Africa: Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 248 Middle East & Africa: Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2022-2030 (USD Million)
Table 249 Middle East & Africa: Central Lab Services/Clinical Trial Lab Services Market, by Biologics, 2022-2030 (USD Million)
Table 250 Middle East & Africa: Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2022-2030 (USD Million)
Table 251 Overview of Strategies Adopted by Key Players in Central Lab Services/Clinical Trial Lab Services Market, 2022-2025
Table 252 Central Lab Services/Clinical Trial Lab Services Market: Degree of Competition
Table 253 Central Lab Services/Clinical Trial Lab Services Market: Region Footprint
Table 254 Central Lab Services/Clinical Trial Lab Services Market: Product Type Footprint
Table 255 Central Lab Services/Clinical Trial Lab Services Market: Therapeutic Area Footprint
Table 256 Central Lab Services/Clinical Trial Lab Services Market: Phase Footprint
Table 257 Central Lab Services/Clinical Trial Lab Services Market: Detailed List of Key Startups/SMEs
Table 258 Central Lab Services/Clinical Trial Lab Services Market: Competitive Benchmarking of Key Startups/SMEs
Table 259 Central Lab Services/Clinical Trial Lab Services Market: Product Launches, January 2022-January 2025
Table 260 Central Lab Services/Clinical Trial Lab Services Market: Deals, January 2022-January 2025
Table 261 Central Lab Services/Clinical Trial Lab Services Market: Expansions, January 2022-January 2025
Table 262 Central Lab Services/Clinical Trial Lab Services Market: Other Developments, January 2022-January 2025
Table 263 Thermo Fisher Scientific Inc.: Company Overview
Table 264 Thermo Fisher Scientific Inc.: Products/Services Offered
Table 265 Thermo Fisher Scientific Inc.: Product Launches, January 2022- January 2025
Table 266 Thermo Fisher Scientific Inc.: Deals, January 2022-January 2025
Table 267 Thermo Fisher Scientific Inc.: Expansions, January 2022-January 2025
Table 268 Iqvia: Company Overview
Table 269 Iqvia: Products/Services Offered
Table 270 Iqvia: Product Launches, January 2022-January 2025
Table 271 Iqvia: Deals, January 2022-January 2025
Table 272 Icon PLC: Company Overview
Table 273 Icon PLC: Products/Services Offered
Table 274 Icon PLC: Product Launches, January 2022-January 2025
Table 275 Icon PLC: Deals, January 2022-January 2025
Table 276 Charles River Laboratories: Company Overview
Table 277 Charles River Laboratories: Products/Services Offered
Table 278 Charles River Laboratories: Deals, January 2022-January 2025
Table 279 Charles River Laboratories: Expansions, January 2022-January 2025
Table 280 Labcorp: Company Overview
Table 281 Labcorp: Products/Services Offered
Table 282 Labcorp: Products Launches, January 2022-January 2025
Table 283 Labcorp: Deals, January 2022-January 2025
Table 284 Labcorp: Expansions, January 2022-January 2025
Table 285 Labcorp: Other Developments, January 2022-January 2025
Table 286 Quest Diagnostics: Company Overview
Table 287 Quest Diagnostics: Products/Services Offered
Table 288 Quest Diagnostics: Deals, January 2022-January 2025
Table 289 Medpace: Company Overview
Table 290 Medpace: Products/Services Offered
Table 291 Medpace: Expansions, January 2022-January 2025
Table 292 Frontage Labs: Company Overview
Table 293 Frontage Labs: Products/Services Offered
Table 294 Sgs Société Générale De Surveillance SA: Company Overview
Table 295 Sgs Société Générale De Surveillance SA: Products/Services Offered
Table 296 Sgs Société Générale De Surveillance SA: Deals, January 2022- January 2025
Table 297 Eurofins Scientific: Company Overview
Table 298 Eurofins Scientific: Products/Services Offered
Table 299 Eurofins Scientific: Deals, January 2022-January 2025
Table 300 Reprocell Inc.: Company Overview
Table 301 Reprocell Inc.: Products/Services Offered
Table 302 Reprocell Inc.: Deals, January 2022-January 2025
Table 303 Acm Global Laboratories: Company Overview
Table 304 Acm Global Laboratories: Products/Services Offered
Table 305 Acm Global Laboratories: Deals, January 2022-January 2025
Table 306 Worldwide Clinical Trials: Company Overview
Table 307 Versiti: Company Overview
Table 308 Cti Clinical Trial & Consulting: Company Overview
Table 309 Clarity Laboratories, Inc.: Company Overview
Table 310 Novotech: Company Overview
Table 311 Arup Laboratories: Company Overview
Table 312 Precision Medicine Group: Company Overview
Table 313 Bioagilytix Labs: Company Overview
Table 314 Cerba Healthcare: Company Overview
Table 315 Almac Group: Company Overview
Table 316 Mlm Medical Labs: Company Overview
Table 317 Salvus Bioresearch Solutions Llp: Company Overview
Table 318 Unilabs: Company Overview

List of Figures

Figure 1 Central Lab Services/Clinical Trial Lab Services Market Segmentation and Regional Scope
Figure 2 Central Lab Services/Clinical Trial Lab Services Market: Research Design
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 4 Company Revenue Estimation Approach: Bottom-Up Approach
Figure 5 CAGR Projections: Supply-Side Analysis
Figure 6 Central Lab Services/Clinical Trial Lab Services Market: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Central Lab Services/Clinical Trial Lab Services Market, by Phase, 2025 vs. 2030 (USD Million)
Figure 9 Central Lab Services/Clinical Trial Lab Services Market, by Service Type, 2025 vs. 2030 (USD Million)
Figure 10 Central Lab Services/Clinical Trial Lab Services Market, by Therapeutic Area, 2025 vs. 2030 (USD Million)
Figure 11 Central Lab Services/Clinical Trial Lab Services Market, by Modality, 2025 vs. 2030 (USD Million)
Figure 12 Central Lab Services/Clinical Trial Lab Services Market, by End-user, 2025 vs. 2030 (USD Million)
Figure 13 Geographical Snapshot of Central Lab Services/Clinical Trial Lab Services Market
Figure 14 Increasing Prevalence of Rare Diseases to Drive Market
Figure 15 Pharmaceutical & Biopharmaceutical Companies Segment and China Led Asia-Pacific Market in 2024
Figure 16 China to Record Highest Growth Rate from 2025 to 2030
Figure 17 Asia-Pacific to Witness Highest Growth During Forecast Period
Figure 18 Central Lab Services/Clinical Trial Lab Services Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Trends/Disruptions Impacting Customer Business
Figure 20 Central Lab Services/Clinical Trial Lab Services Market: Value Chain Analysis
Figure 21 Central Lab Services/Clinical Trial Lab Services Market: Ecosystem Analysis
Figure 22 Central Lab Services/Clinical Trial Lab Services Market: Investment and Funding Scenario, 2022-2025
Figure 23 Central Lab Services/Clinical Trial Lab Services Market: Porter's Five Forces Analysis
Figure 24 Influence of Stakeholders on Buying Process, by End-user
Figure 25 Key Buying Criteria, by End-user
Figure 26 AI Use Cases
Figure 27 North America: Central Lab Services/Clinical Trial Lab Services Market Snapshot
Figure 28 Asia-Pacific: Central Lab Services/Clinical Trial Lab Services Market Snapshot
Figure 29 Revenue Analysis of Key Players, 2020-2024 (USD Million)
Figure 30 Market Share Analysis of Key Players, 2024
Figure 31 Ranking of Key Players in Central Lab Services/Clinical Trial Lab Services Market, 2024
Figure 32 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors, 2025
Figure 33 Financial Metrics, 2025
Figure 34 Central Lab Services/Clinical Trial Lab Services Market: Brand/Product Comparison
Figure 35 Central Lab Services/Clinical Trial Lab Services Market: Company Evaluation Matrix (Key Players), 2024
Figure 36 Central Lab Services/Clinical Trial Lab Services Market: Company Footprint
Figure 37 Central Lab Services/Clinical Trial Lab Services Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 38 Thermo Fisher Scientific Inc.: Company Snapshot (2024)
Figure 39 Iqvia: Company Snapshot (2024)
Figure 40 Icon PLC: Company Snapshot (2023)
Figure 41 Charles River Laboratories: Company Snapshot (2023)
Figure 42 Labcorp: Company Snapshot (2024)
Figure 43 Quest Diagnostics: Company Snapshot (2024)
Figure 44 Medpace: Company Snapshot (2024)
Figure 45 Frontage Labs: Company Snapshot (2023)
Figure 46 Sgs Société Générale De Surveillance SA: Company Snapshot (2024)
Figure 47 Eurofins Scientific: Company Snapshot (2024)

Companies Mentioned

Thermo Fisher Scientific Inc.
Iqvia
Icon PLC
Charles River Laboratories
Labcorp
Quest Diagnostics
Medpace
Frontage Labs
Sgs Société Générale De Surveillance SA
Eurofins Scientific
Reprocell Inc.
Acm Global Laboratories
Worldwide Clinical Trials
Versiti
Cti Clinical Trial & Consulting
Clarity Laboratories, Inc
Novotech
Arup Laboratories
Precision Medicine Group
Bioagilytix Labs
Cerba Healthcare
Almac Group
Mlm Medical Labs
Salvus Bioresearch Solutions Llp
Unilabs

Table Information

Report Attribute	Details
No. of Pages	311
Published	March 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 5.97 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.18 Billion
Compound Annual Growth Rate	6.5%
Regions Covered	Global
No. of Companies Mentioned	25

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4706EUR$4,950USD£3,958GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6323EUR$6,650USD£5,317GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7749EUR$8,150USD£6,516GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9508EUR$10,000USD£7,995GBP

Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area (Oncology), Modality (Small Molecules, Vaccine), End User (Pharma & CROs) & Region - Global Forecast to 2030

The pharmaceutical & biopharmaceutical companies segment of central lab services/clinical trial lab services market by end user to hold largest position forecast period.

The oncology segment accounts for the largest market share in central lab services/clinical trial lab services market.

Asia Pacific is the fastest growing region of the central lab services/clinical trial lab services market by region.

A breakdown of the primary participants referred to for this report is provided below:

Research Coverage

Reasons to Buy the Report

This report provides insights on the following pointers:

Table of Contents

Companies Mentioned

Table Information

The pharmaceutical & biopharmaceutical companies segment of central lab services/clinical trial lab services market by end user to hold largest position forecast period.

The oncology segment accounts for the largest market share in central lab services/clinical trial lab services market.

Asia Pacific is the fastest growing region of the central lab services/clinical trial lab services market by region.

A breakdown of the primary participants referred to for this report is provided below:

Research Coverage

Reasons to Buy the Report

This report provides insights on the following pointers:

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Therapeutic Area (Autoimmune Diseases, Cardiovascular Diseases, Infectious Diseases), Phase, End-User Industries - Global Forecast 2025-2030

Central Lab Market Size, Share & Trends Analysis Report by Service (Genetic Services, Biomarker Services), End-use (Pharmaceutical Companies, Biotechnology Companies), Region, and Segment Forecasts, 2024-2030

Central Lab Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

Contract Research Organization (CRO) Services: Global Markets

Central Lab Market By Services (Genetic services, Biomarker services, Anatomic pathology and histology, Specimen management and storage, Others), By End user (Pharmaceutical companies, Biotechnology companies, Others): Global Opportunity Analysis and Industry Forecast, 2022-2031